ALPHA TRIBE

Suraksha Diagnostic LimitedUpdates, 05-02-2026: Press Release

05-02-2026 | 05:22 pm

Suraksha Diagnostic's Q3 FY26 revenue jumped 30.3% to ₹78.31 Cr, with EBITDA up 26.1% to ₹23.78 Cr and PAT rising 21% to ₹7.24 Cr. Strong growth driven by network expansion and 30.7% higher test volumes. The company launched a new genomics vertical.

No comments yet. Be the first to comment!

All announcements from Suraksha Diagnostic Limited